Dr. Michael Demeure is the Program Director for Precision Medicine at the Hoag Family Cancer Institute and a fellowship-trained endocrine surgeon with the Newport Irvine Surgical Specialists group. He is a Clinical Professor of Surgery at the University of Arizona, College of Medicine in Phoenix. He previously practiced in Scottsdale Arizona.
Dr. Demeure has also served as a Clinical Professor at the Translational Genomics Research Institute since 2004, and is now a member of the Adjunct Faculty since moving to Newport Beach in May 2017. Over the past 3 years, Dr. Demeure assisted TGEN with the launch and direction of Ashion, a commercial clinical sequencing lab, serving as the chief medical officer, executive vice-president, and general manager in the organization. Under Dr. Demeure’s direction, Ashion garnered accreditation by the College of American Pathologists and built a business infrastructure. He negotiated several research and payer contracts.
Dr. Demeure’s clinical focus is on tumors of the thyroid, parathyroid, adrenal glands and pancreas, and he also continues to practice general surgery. Dr. Demeure is an internationally recognized expert in cancer surgery and research with particular expertise in endocrine, pancreatic, and gastrointestinal cancers. While maintaining a very busy clinical practice and performing over 300 major operations annually, Dr. Demeure has led an active research lab for over 20 years with the majority of those efforts centered on using genomic technologies to develop novel biomarkers, new therapeutic targets, and related therapies in the management of endocrine and gastrointestinal cancers. His efforts have included his participation as a Co-Investigator or Principle Investigator for some of the landmark trials in these same areas. Dr. Demeure is the author or co-author of over 100 scholarly works, and he has given over 150 invited lectures and presentations.
As the chief of general surgery at the University of Arizona, Dr. Demeure led the student clerkship to excellence, recognized by his department winning an award for the best clerkship, designated by the graduating students. Dr. Demeure also led several quality programs and was responsible for recruiting. In his first three years in his role, he led the division to financial profitability from a recurring yearly deficit.
Dr. Demeure is a graduate of Hahnemann Medical College and completed his surgical residency at the University of Arizona. He subsequently completed a fellowship in endocrine surgery in Perth, Australia and at the University of California, San Francisco. He previously held faculty positions at the Medical College of Wisconsin, as Professor and Chief of General Surgery at the University of Arizona, and most recently as Scientific Director, Center for Pancreatic and Endocrine Surgery, Scottsdale Healthcare, and Professor and Director of the Rare Tumors Program in the Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen). In 2007, Dr. Demeure completed his Master’s Degree in Business Administration at the University of Arizona.
Dr. Demeure is a past-President of the American Association of Endocrine Surgeons. He is regularly recognized as one of “America’s Top Surgeons” and has been named as one of the “Best Doctors in America” every year since 2001. For the past two years, he has been recognized as one of Phoenix Magazine’s Top Doctors, an honor bestowed by a survey of local physician peers. Local service includes serving on the board of directors of the Arizona State Physicians Association from 2013-2015.
Dr. Demeure was born in New York City and grew up in Pittsburgh, PA. His father was from Belgium and his mother is from Argentina; as such Dr. Demeure speaks both Spanish and French in addition to English. He and his wife Sara have two daughters and a son. Dr. Demeure has a black belt in Taekwondo and is currently studying Kung fu. His other interests include reading, cooking, photography, and skiing.